# RescuE pLAsma eXchange in Severe COVID-19

> **NCT04685655** · NA · TERMINATED · sponsor: **Heidelberg University** · enrollment: 67 (actual)

## Conditions studied

- Therapeutic Plasma Exchange
- Covid19

## Interventions

- **OTHER:** Therapeutic plasma exchange

## Key facts

- **NCT ID:** NCT04685655
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-07
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Low numbers of severe COVID-19 cases with current variants.
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04685655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04685655, "RescuE pLAsma eXchange in Severe COVID-19". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT04685655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*